Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,865 | 13 | 57.6% |
| Food and Beverage | $3,800 | 212 | 18.4% |
| Honoraria | $2,673 | 2 | 13.0% |
| Consulting Fee | $1,928 | 4 | 9.4% |
| Education | $294.12 | 8 | 1.4% |
| Gift | $45.00 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $9,956 | 63 | $0 (2024) |
| PFIZER INC. | $5,880 | 30 | $0 (2024) |
| GENZYME CORPORATION | $1,989 | 5 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $481.49 | 46 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $349.90 | 10 | $0 (2023) |
| Janssen Biotech, Inc. | $273.53 | 13 | $0 (2024) |
| ABBVIE INC. | $212.81 | 15 | $0 (2024) |
| Boston Scientific Corporation | $152.57 | 3 | $0 (2020) |
| Janssen Scientific Affairs, LLC | $132.72 | 2 | $0 (2017) |
| NeoTract Inc. | $123.37 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $471.67 | 35 | Sumitomo Pharma America, Inc. ($215.24) |
| 2023 | $754.92 | 40 | Sumitomo Pharma America, Inc. ($266.25) |
| 2022 | $3,377 | 20 | PFIZER INC. ($2,979) |
| 2021 | $1,940 | 9 | GENZYME CORPORATION ($1,808) |
| 2020 | $721.82 | 20 | Astellas Pharma US Inc ($524.75) |
| 2019 | $8,433 | 51 | Astellas Pharma US Inc ($5,632) |
| 2018 | $4,095 | 38 | Astellas Pharma US Inc ($3,649) |
| 2017 | $811.20 | 27 | Dendreon Pharmaceuticals LLC ($210.83) |
All Payment Transactions
240 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: UROLOGY | ||||||
| 12/04/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $2.07 | General |
| Category: UROLOGY | ||||||
| 11/27/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $10.20 | General |
| Category: UROLOGY | ||||||
| 10/09/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Oncology | ||||||
| 10/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $8.55 | General |
| Category: UROLOGY | ||||||
| 09/30/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Oncology | ||||||
| 09/30/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $7.58 | General |
| Category: UROLOGY | ||||||
| 09/30/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $0.56 | General |
| Category: UROLOGY | ||||||
| 09/25/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $8.94 | General |
| Category: UROLOGY | ||||||
| 09/16/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $28.48 | General |
| 09/03/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $27.72 | General |
| Category: SURGERY | ||||||
| 08/14/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $8.00 | General |
| Category: UROLOGY | ||||||
| 08/14/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $1.16 | General |
| Category: UROLOGY | ||||||
| 06/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $10.51 | General |
| Category: UROLOGY | ||||||
| 06/12/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $1.23 | General |
| Category: UROLOGY | ||||||
| 06/05/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: UROLOGY | ||||||
| 05/30/2024 | Baxter Healthcare | FLOSEAL (Biological) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Surgical Care | ||||||
| 05/29/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $7.28 | General |
| Category: UROLOGY | ||||||
| 05/29/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $0.50 | General |
| Category: UROLOGY | ||||||
| 05/22/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $9.55 | General |
| Category: UROLOGY | ||||||
| 05/01/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $9.63 | General |
| Category: UROLOGY | ||||||
| 03/22/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: UROLOGY | ||||||
| 03/22/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $3.04 | General |
| Category: UROLOGY | ||||||
| 03/14/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 892 | 1,281 | $1.4M | $127,802 |
| 2022 | 20 | 999 | 1,372 | $1.2M | $133,401 |
| 2021 | 19 | 1,084 | 1,451 | $460,957 | $115,440 |
| 2020 | 23 | 1,462 | 1,865 | $371,955 | $101,043 |
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 29 | 228 | $986,574 | $30,410 | 3.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 198 | 234 | $44,583 | $19,617 | 44.0% |
| 50543 | Partial removal of kidney using an endoscope | Facility | 2023 | 16 | 16 | $84,608 | $17,548 | 20.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 80 | 106 | $67,840 | $15,934 | 23.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 228 | 256 | $33,615 | $15,021 | 44.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 34 | 34 | $10,109 | $3,741 | 37.0% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 17 | 17 | $16,813 | $3,722 | 22.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 25 | $6,522 | $3,385 | 51.9% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 19 | 19 | $11,305 | $3,251 | 28.8% |
| 52235 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | Facility | 2023 | 12 | 13 | $21,463 | $2,560 | 11.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 47 | 57 | $4,980 | $2,324 | 46.7% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 25 | 27 | $47,295 | $2,206 | 4.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 20 | $5,132 | $1,975 | 38.5% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 19 | 19 | $8,702 | $1,948 | 22.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $4,260 | $1,545 | 36.3% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 29 | 46 | $4,968 | $1,157 | 23.3% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 29 | 34 | $3,196 | $639.20 | 20.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 11 | $1,540 | $601.80 | 39.1% |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | Office | 2023 | 19 | 57 | $309.51 | $125.39 | 40.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 16 | 42 | $882.00 | $92.40 | 10.5% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 25 | 183 | $779,031 | $23,432 | 3.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 197 | 237 | $46,452 | $20,686 | 44.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 86 | 108 | $69,120 | $17,945 | 26.0% |
| 50543 | Partial removal of kidney using an endoscope | Facility | 2022 | 14 | 14 | $74,032 | $15,808 | 21.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 219 | 248 | $33,480 | $13,476 | 40.3% |
About Dr. George Martin, M.D
Dr. George Martin, M.D is a Urology healthcare provider based in Fort Wayne, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841222452.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Martin, M.D has received a total of $20,605 in payments from pharmaceutical and medical device companies, with $471.67 received in 2024. These payments were reported across 240 transactions from 38 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($11,865).
As a Medicare-enrolled provider, Martin has provided services to 4,437 Medicare beneficiaries, totaling 5,969 services with total Medicare billing of $477,687. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Fort Wayne, IN
- Active Since 07/06/2006
- Last Updated 11/16/2022
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1841222452
Products in Payments
- XTANDI (Drug) $11,419
- JEVTANA (Drug) $2,031
- GEMTESA (Drug) $557.26
- PROVENGE (Drug) $349.90
- ERLEADA (Drug) $181.30
- TOVIAZ (Drug) $135.11
- DIREXION (Device) $121.39
- DARZALEX (Biological) $113.75
- LUPRON DEPOT (Drug) $107.22
- Urolift - UL400 (Device) $75.86
- Xtandi (Drug) $61.20
- Lupron (Drug) $53.90
- ZYTIGA (Drug) $51.49
- Axumin (Drug) $48.09
- UroLift (Device) $47.51
- Prolia (Biological) $45.10
- Noctiva (Drug) $45.06
- Da Vinci Surgical System (Device) $42.56
- Erleada (Drug) $40.74
- ENDO CLIP III (Device) $40.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Fort Wayne
David Pollifrone, Md, MD
Urology — Payments: $27,974
Mark Dabagia, Md, MD
Urology — Payments: $16,775
Dr. David Turk, Md, MD
Urology — Payments: $10,321
Adam Thomas, Md, MD
Urology — Payments: $9,310
Claire Aubrey, D.o, D.O
Urology — Payments: $6,018
Dr. Eric Hick, D.o, D.O
Urology — Payments: $5,800